Vor Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vor Biopharma and other ETFs, options, and stocks.

About VOR

Vor Biopharma, Inc. is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. It is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and potential commercialization to address serious autoantibody-driven conditions worldwide. 

CEO
Jean-Paul Kress
CEOJean-Paul Kress
Employees
76
Employees76
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2015
Founded2015
Employees
76
Employees76

VOR Key Statistics

Market cap
1.36B
Market cap1.36B
Price-Earnings ratio
-0.28
Price-Earnings ratio-0.28
Dividend yield
Dividend yield
Average volume
754.03K
Average volume754.03K
High today
$23.35
High today$23.35
Low today
$22.38
Low today$22.38
Open price
$23.33
Open price$23.33
Volume
409.24K
Volume409.24K
52 Week high
$50.20
52 Week high$50.20
52 Week low
$6.50
52 Week low$6.50

Stock Snapshot

Vor Biopharma(VOR) stock is priced at $23.03, giving the company a market capitalization of 1.36B. It carries a P/E multiple of -0.28.

On 2026-08-16, Vor Biopharma(VOR) stock traded between a low of $22.38 and a high of $23.35. Shares are currently priced at $23.03, which is +2.9% above the low and -1.4% below the high.

The Vor Biopharma(VOR)'s current trading volume is 409.24K, compared to an average daily volume of 754.03K.

During the past year, Vor Biopharma(VOR) stock moved between $6.50 at its lowest and $50.20 at its peak.

During the past year, Vor Biopharma(VOR) stock moved between $6.50 at its lowest and $50.20 at its peak.

VOR News

Simply Wall St 3d
Vor Biopharma Stock Looks Reasonable On Earnings Yet Weak On Broader Checks

Vor Biopharma has seen its share price fall about 92.0% over the past five years, even as current valuation checks on the stock now point to a mixed picture rat...

Vor Biopharma Stock Looks Reasonable On Earnings Yet Weak On Broader Checks

Analyst ratings

89%

of 9 ratings
Buy
88.9%
Hold
11.1%
Sell
0%

People also own

Based on the portfolios of people who own VOR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.